{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:36:15Z","timestamp":1762522575513,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Emerg Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may not elicit lifelong protective immunity and reinfection could occur. Liver function impairment is a common manifestation of coronavirus disease 2019 (COVID-19). However, acute hepatic failure in the setting of COVID-19 is very rare.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report the case of a 47-year-old woman who presented with acute abdominal pain and vomiting. Abdominal examination revealed a soft and lax abdomen with mild tenderness in the right upper quadrant. The patient recovered from COVID-19 2 months previously with negative results on reverse transcription-polymerase chain reaction (RT-PCR). Laboratory investigations revealed markedly elevated transaminases with normal results on viral hepatitis serology panel and undetectable blood paracetamol level. Prior to admission, the patient underwent RT-PCR for SARS-CoV-2, which revealed a positive result. The patient experienced rapid deterioration in the neurological status with a remarkable increase in the liver enzyme levels. Despite aggressive resuscitation, the patient suffered irreversible cardiac arrest and died.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Fulminant hepatic failure is a rare manifestation in patients with re-positive RT-PCR tests for SARS-CoV-2. Clinicians should maintain a high index of suspicion for hepatic injury with active monitoring of liver enzymes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12245-021-00349-6","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T12:22:32Z","timestamp":1619007752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fulminant hepatic failure in a patient testing re-positive for SARS-CoV-2: a case report"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4788-4424","authenticated-orcid":false,"given":"Bader","family":"Aldossary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6485-5460","authenticated-orcid":false,"given":"Ali","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4496-9708","authenticated-orcid":false,"given":"Mohamed","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1376-7652","authenticated-orcid":false,"given":"Hind S.","family":"Alsaif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7798-1885","authenticated-orcid":false,"given":"Dunya","family":"Alfaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"349_CR1","doi-asserted-by":"crossref","unstructured":"Tillett RL, Sevinsky JR, Hartley PD, Kerwin H, Crawford N, Gorzalski A, et al. Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet Infect Dis. 2020.","DOI":"10.2139\/ssrn.3680955"},{"key":"349_CR2","doi-asserted-by":"crossref","unstructured":"To KK, Hung IF, Ip JD, Chu AW, Chan WM, Tam AR, et al. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clin Infect Dis. 2020.","DOI":"10.1093\/cid\/ciaa1275"},{"key":"349_CR3","unstructured":"Van Elslande J, Vermeersch P, Vandervoort K, Wawina-Bokalanga T, Vanmechelen B, Wollants E, et al. Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain. Clin Infect Dis. 2020."},{"key":"349_CR4","unstructured":"Mulder M, van der Vegt D, Oude Munnink BB, GeurtsvanKessel CH, van de Bovenkamp J, Sikkema RS, et al. Reinfection of SARS-CoV-2 in an immunocompromised patient: a case report. Clin Infect Dis. 2020:ciaa1538."},{"issue":"13","key":"349_CR5","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239\u201342. https:\/\/doi.org\/10.1001\/jama.2020.2648.","journal-title":"JAMA"},{"issue":"2","key":"349_CR6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/hep.20111","volume":"39","author":"TN Chau","year":"2004","unstructured":"Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, Yeung YC, et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. 2004;39(2):302\u201310. https:\/\/doi.org\/10.1002\/hep.20111.","journal-title":"Hepatology"},{"issue":"5","key":"349_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","volume":"5","author":"C Zhang","year":"2020","unstructured":"Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5(5):428\u201330. https:\/\/doi.org\/10.1016\/S2468-1253(20)30057-1.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"349_CR8","doi-asserted-by":"crossref","unstructured":"Melquist S, Estepp K, Aleksandrovich Y, Lee A, Beiseker A, Hamedani FS, et al. COVID-19 presenting as fulminant hepatic failure: a case report. Medicine. 2020:99(43).","DOI":"10.1097\/MD.0000000000022818"},{"key":"349_CR9","doi-asserted-by":"publisher","first-page":"100748","DOI":"10.1016\/j.nmni.2020.100748","volume":"37","author":"AA Osman","year":"2020","unstructured":"Osman AA, Al Daajani MM, Alsahafi AJ. Re-positive coronavirus disease 2019 PCR test: could it be a reinfection? New Microbes New Infect. 2020;37:100748. https:\/\/doi.org\/10.1016\/j.nmni.2020.100748.","journal-title":"New Microbes New Infect"},{"issue":"1","key":"349_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S1473-3099(20)30764-7","volume":"21","author":"RL Tillett","year":"2021","unstructured":"Tillett RL, Sevinsky JR, Hartley PD, Kerwin H, Crawford N, Gorzalski A, et al. Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet Infect Dis. 2021;21(1):52\u20138. https:\/\/doi.org\/10.1016\/S1473-3099(20)30764-7.","journal-title":"Lancet Infect Dis"},{"key":"349_CR11","unstructured":"Wang S, Han P, Xiao F. Manifestations of liver injury in 333 hospitalized patients with coronavirus disease 2019. Chin J Dig. 2020:40(3)."},{"issue":"2","key":"349_CR12","first-page":"148","volume":"28","author":"C Liu","year":"2020","unstructured":"Liu C, Jiang Z, Shao C, Zhang H, Yue H, Chen Z, et al. Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study. Zhonghua gan zang bing za zhi= Zhonghua ganzangbing zazhi=. Chin J Hepatol. 2020;28(2):148\u201352.","journal-title":"Chin J Hepatol"},{"issue":"4","key":"349_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420\u20132. https:\/\/doi.org\/10.1016\/S2213-2600(20)30076-X.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"349_CR14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","volume":"24","author":"W Ni","year":"2020","unstructured":"Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020;24(1):422. https:\/\/doi.org\/10.1186\/s13054-020-03120-0.","journal-title":"Crit Care"},{"key":"349_CR15","doi-asserted-by":"crossref","unstructured":"Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv. 2020:2020.2002.2003.931766.","DOI":"10.1101\/2020.02.03.931766"},{"issue":"3","key":"349_CR16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","volume":"73","author":"Q Cai","year":"2020","unstructured":"Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, et al. COVID-19: abnormal liver function tests. J Hepatol. 2020;73(3):566\u201374. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.006.","journal-title":"J Hepatol"},{"issue":"6","key":"349_CR17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.rec.2020.04.004","volume":"73","author":"F Soria Arcos","year":"2020","unstructured":"Soria Arcos F, Romero Puche A, Vicente Vera T. Controversy regarding ACE inhibitors\/ARBs in COVID-19. Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition). 2020;73(6):516.","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"349_CR18","doi-asserted-by":"crossref","unstructured":"Napodano C, Pocino K, Stefanile A, Marino M, Miele L, Gulli F, Basile V, Pandolfi F, Gasbarrini A, Rapaccini GL et al: COVID-19 and hepatic involvement: the liver as a main actor of the pandemic novel. Scand J Immunol 2020, n\/a(n\/a):e12977.","DOI":"10.1111\/sji.12977"},{"key":"349_CR19","doi-asserted-by":"crossref","unstructured":"Li L, Li S, Xu M, Yu P, Zheng S, Duan Z, et al. Risk factors related to hepatic injury in patients with corona virus disease 2019. medRxiv. 2020:2020.2002.2028.20028514.","DOI":"10.1101\/2020.02.28.20028514"},{"issue":"10","key":"349_CR20","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/jmv.26036","volume":"92","author":"D Tian","year":"2020","unstructured":"Tian D, Ye Q. Hepatic complications of COVID-19 and its treatment. J Med Virol. 2020;92(10):1818\u201324. https:\/\/doi.org\/10.1002\/jmv.26036.","journal-title":"J Med Virol"},{"issue":"13","key":"349_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014992","volume":"98","author":"NH Lin","year":"2019","unstructured":"Lin NH, Yang HW, Su YJ, Chang CW. Herb induced liver injury after using herbal medicine: a systemic review and case-control study. Medicine (Baltimore). 2019;98(13):e14992. https:\/\/doi.org\/10.1097\/MD.0000000000014992.","journal-title":"Medicine (Baltimore)"}],"container-title":["International Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-021-00349-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12245-021-00349-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-021-00349-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T12:26:19Z","timestamp":1619007979000},"score":1,"resource":{"primary":{"URL":"https:\/\/intjem.biomedcentral.com\/articles\/10.1186\/s12245-021-00349-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["349"],"URL":"https:\/\/doi.org\/10.1186\/s12245-021-00349-6","relation":{},"ISSN":["1865-1372","1865-1380"],"issn-type":[{"type":"print","value":"1865-1372"},{"type":"electronic","value":"1865-1380"}],"subject":[],"published":{"date-parts":[[2021,4,21]]},"assertion":[{"value":"26 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s next of kin for the publication of this paper and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this medical journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}